Ryan Cawood Pioneers Lab Data Solutions with £750k Fund
Funding | Jul 07, 2025 | Mercia Fund Management (Mercia Ventures)
Ryan Cawood, the entrepreneur behind the successful biotech company OXGENE, has secured £750,000 in funding for his new venture, Lab Thread, through Mercia Ventures and the Midlands Engine Investment Fund II. Lab Thread aims to provide an advanced, cost-effective software solution for laboratory data management, addressing inefficiencies in current systems that hinder researchers. Collaborating with former colleague Deyan Sultov, the company plans to integrate DNA visualization, sample inventory, and project management into their platform, significantly improving research efficiency. The global laboratory software market is expected to grow considerably, and Lab Thread intends to meet the increasing demand. Mercia Ventures believes in Ryan's ability to innovate, praising the entrepreneurial spirit and foresight necessary to make Lab Thread successful. Dave Tindall from the British Business Bank echoes this optimism, emphasizing the investment's potential to transform the laboratory software sector.
Sectors
- Biotechnology
- Software Development
- Venture Capital
Geography
- United Kingdom – The article discusses a UK-based entrepreneur and the Midlands Engine Investment Fund, which supports businesses within the UK.
- Midlands Region – The funding comes from the Midlands Engine Investment Fund, targeting businesses poised for growth within this UK region.
Industry
- Biotechnology – The article involves Ryan Cawood, a renowned figure in biotechnology, and discusses innovations in lab data management, relevant to biotech research.
- Software Development – Lab Thread is focused on developing software solutions to streamline laboratory data management, relevant to the technology industry.
- Venture Capital – Mercia Ventures, a venture capital firm, is financing Lab Thread, emphasizing the importance of investment in tech startups.
Financials
- £750,000 – Funding secured by Lab Thread for development and commercialization.
- $135m – Sale price of Ryan Cawood's previously founded company, OXGENE.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Ryan Cawood | Founder and CEO of Lab Thread | Person | Entrepreneur behind OXGENE and now leading the new venture Lab Thread. |
| Lab Thread | The Target Company | Company | A startup aiming to revolutionize laboratory data management with a comprehensive software platform. |
| Mercia Ventures | Fund Manager/Investor | Company | A private equity firm providing venture capital backing to Lab Thread via the Midlands Engine Investment Fund II. |
| Midlands Engine Investment Fund II | Funding Source | Company | A fund supporting businesses in the Midlands region, invested in Lab Thread. |
| Deyan Sultov | Co-Founder of Lab Thread | Person | Ryan Cawood's former colleague, working together on the Lab Thread venture. |
| British Business Bank | Funder | Company | Supports the Midlands Engine Investment Fund to back high-growth potential businesses. |